Compositions of FSH with high sialylation degree and their use for the preparation of medicaments

Details for Australian Patent Application No. 2002340562 (hide)

Owner Laboratoires Serono SA

Inventors Loumaye, Ernest; Giartosio, Carlo Emanuele

Agent Griffith Hack

Pub. Number AU-B-2002340562

PCT Number PCT/EP02/11501

PCT Pub. Number WO2003/035686

Priority 60/338,088 22.10.01 US

Filing date 15 October 2002

Wipo publication date 6 May 2003

Acceptance publication date 23 October 2008

International Classifications

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

A61K 38/24 (2006.01) Medicinal preparations containing peptides - Follicle-stimulating hormone (FSH)

A61P 5/24 (2006.01) Drugs for disorders of the endocrine system

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

C07K 14/59 (2006.01) Peptides having more than 20 amino acids

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/338,088 22.10.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002340562

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V The application has been assigned to Laboratoires Serono SA

23 October 2008 Application Accepted

  Published as AU-B-2002340562

19 February 2009 Standard Patent Sealed

4 June 2009 Assignment Registered

  Laboratoires Serono SA The patent has been assigned to Merck Serono SA

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002340563-STRETCHED AND VOIDED POLYMERIC FILM

2002340561-Use of peptide vectors to improve the immune response to antigens